Furthermore, trans-retinoic acid combined with interferon-α disrupts the metabolism of CD38 malignant cells, increasing their sensitivity to anti-CD38 antibodies in T cell leukemia [36]. This evidence concerns the gene CD38 and T-cell leukemia.